Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov 16;11(1):35.
doi: 10.1186/s40345-023-00316-5.

Key questions on the long term renal effects of lithium: a review of pertinent data

Affiliations
Review

Key questions on the long term renal effects of lithium: a review of pertinent data

Michael Gitlin et al. Int J Bipolar Disord. .

Abstract

For over half a century, it has been widely known that lithium is the most efficacious maintenance treatment for bipolar disorder. Despite thorough research on the long-term effects of lithium on renal function, a number of important questions relevant to clinical practice remain. The risk of polyuria, reflecting renal tubular dysfunction, is seen in a substantial proportion of patients treated with long term lithium therapy. The duration of lithium may be the most important risk factor for lithium-induced polyuria. Most, but not all, studies find that lithium is associated with higher rates of chronic kidney disease compared to either age matched controls or patients treated with other mood stabilizers. Age, duration of lithium therapy and medical disorders such as hypertension and diabetes mellitus are risk factors for chronic kidney disease in lithium-treated patients. The relationship between polyuria and chronic kidney disease is inconsistent but poorly studied. Although not all studies agree, it is likely that lithium may increase the risk for end stage renal disease but in a very small proportion of treated patients. Patients whose renal function is relatively preserved will show either no progression or improvement of renal function after lithium discontinuation. In contrast, patients with more renal damage frequently show continued deterioration of renal function even after lithium discontinuation. Optimal management of lithium treatment requires obtaining a baseline measure of renal function (typically estimated glomerular filtration rate [eGFR]) and regular monitoring of eGFR during treatment. Should the eGFR fall rapidly or below 60 ml/minute, patients should consider a consultation with a nephrologist. A decision as to whether lithium should be discontinued due to progressive renal insufficiency should be made using a risk/benefit analysis that takes into account other potential etiologies of renal dysfunction, current renal function, and the efficacy of lithium in that individual patient.

Keywords: Bipolar disorder; Kidney function; Maintenance treatment; lithium.

PubMed Disclaimer

Conflict of interest statement

MG has no conflicts of interest to declare with respect to the research, authorship and/or publication of this article. MB has received research grants by the Deutsche Forschungsgemeinschaft (DFG), Bundesministerium für Bildung und Forschung (BMBF), Gemeinsamer Bundesausschuss- Innovationsausschuss, European Commission, Sächsisches Staatsministerium für Wissenschaft, Kultur und Tourismus (SMWK); SAB, and served as consultant, advisor or speaker for Biogen, COMPASS Pathfinder, GH Research, F. Hoffmann-La Roche, Janssen, Janssen-Cilag, Livanova Deutschland GmbH, Novartis, Sunovion, Takeda, neuraxpharm, Shire International GmbH, Aristo, Servier Deutschland GmbH and Hexal AG.

Similar articles

Cited by

References

    1. Aiff H, Attman P, Aurell M, Bendz H, SchÓ§n S, Svedlund J. Effects of 10 to 30 years of lithium treatment on kidney function. J Psychopharmacol. 2015 doi: 10.1177/0269881115573808. - DOI - PubMed
    1. Aiff H, Attman P, Aurell M, Bendz H, SchÓ§n S, Svedlund J. The impact of modern treatment principles may have eliminated lithium-induced Renal Failure. J Psychopharmacol. 2014B; 151–4. - PubMed
    1. Aiff H, Attman P, Aurell M, Bendz H, SchÓ§n S, Svedlund J. End-stage renal Disease associated with prophylactic lithium treatment. Eur Neuropsychopharmacol. 2014A;24:540–4. - PubMed
    1. Azab A, Shnaider A, Osher Y, Wang D, Bersudsky Y, Belmaker RH. Lithium nephrotoxicity. Int J Bipolar Disorders. 2015;3:13. doi: 10.1186/s40345-015-0028-y. - DOI - PMC - PubMed
    1. Bassilios N, Martel P, Godard V, Froissart M, Grϋnfeld J. Stengel B on behalf of the Réseau Néphropar. Monitoring of glomerular filtration rate in lithium-treated outpatients-an ambulatory laboratory database surveillance. Nephrol Dial Transplant. 2008;23:562–5. doi: 10.1093/ndt/gfm567. - DOI - PubMed